NCT05250284 The Intersection of Oncology Care and Worker Well-Being
| NCT ID | NCT05250284 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Solid Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-04-04 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2022-04-04 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12-month observation period, the investigators will learn whether these men work long-term and how work status relates to well-being.
Eligibility Criteria
Inclusion Criteria: * Males * Ages 21 to 70 * Newly diagnosed with a first primary solid tumor * colorectal, lung, and head and neck * Currently employed (defined as working 10+ hours per week) with the intention to continue working or return to work * Within 2 months of initiating infusion chemotherapy, oral agent, or radiation therapy
Contact & Investigator
Cathy Bradley
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05250284 clinical trial?
This trial is open to male participants only, aged 21 Years or older, up to 70 Years, studying Solid Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05250284 currently recruiting?
Yes, NCT05250284 is actively recruiting participants. Contact the research team at carol.brown@cuanschutz.edu for enrollment information.
Where is the NCT05250284 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05250284 clinical trial?
NCT05250284 is sponsored by University of Colorado, Denver. The principal investigator is Cathy Bradley at University of Colorado, Denver. The trial plans to enroll 400 participants.